Back to Search
Start Over
Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro.
- Source :
-
PloS one [PLoS One] 2015 Apr 22; Vol. 10 (4), pp. e0124373. Date of Electronic Publication: 2015 Apr 22 (Print Publication: 2015). - Publication Year :
- 2015
-
Abstract
- Haemophilus ducreyi resists the cytotoxic effects of human antimicrobial peptides (APs), including α-defensins, β-defensins, and the cathelicidin LL-37. Resistance to LL-37, mediated by the sensitive to antimicrobial peptide (Sap) transporter, is required for H. ducreyi virulence in humans. Cationic APs are attracted to the negatively charged bacterial cell surface. In other gram-negative bacteria, modification of lipopolysaccharide or lipooligosaccharide (LOS) by the addition of positively charged moieties, such as phosphoethanolamine (PEA), confers AP resistance by means of electrostatic repulsion. H. ducreyi LOS has PEA modifications at two sites, and we identified three genes (lptA, ptdA, and ptdB) in H. ducreyi with homology to a family of bacterial PEA transferases. We generated non-polar, unmarked mutants with deletions in one, two, or all three putative PEA transferase genes. The triple mutant was significantly more susceptible to both α- and β-defensins; complementation of all three genes restored parental levels of AP resistance. Deletion of all three PEA transferase genes also resulted in a significant increase in the negativity of the mutant cell surface. Mass spectrometric analysis revealed that LptA was required for PEA modification of lipid A; PtdA and PtdB did not affect PEA modification of LOS. In human inoculation experiments, the triple mutant was as virulent as its parent strain. While this is the first identified mechanism of resistance to α-defensins in H. ducreyi, our in vivo data suggest that resistance to cathelicidin LL-37 may be more important than defensin resistance to H. ducreyi pathogenesis.
- Subjects :
- Administration, Oral
Adult
Anti-Bacterial Agents therapeutic use
Antimicrobial Cationic Peptides pharmacology
Bacterial Proteins metabolism
Chancroid drug therapy
Chancroid microbiology
Chancroid pathology
Ciprofloxacin therapeutic use
Ethanolaminephosphotransferase metabolism
Ethanolamines metabolism
Female
Gene Deletion
Gene Expression
Genetic Complementation Test
Haemophilus ducreyi drug effects
Haemophilus ducreyi metabolism
Haemophilus ducreyi pathogenicity
Healthy Volunteers
Humans
Lipid A chemistry
Male
Mutation
Protein Binding
Static Electricity
alpha-Defensins pharmacology
beta-Defensins pharmacology
Cathelicidins
Bacterial Proteins genetics
Drug Resistance, Bacterial genetics
Ethanolaminephosphotransferase genetics
Haemophilus ducreyi genetics
Lipid A metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 10
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 25902140
- Full Text :
- https://doi.org/10.1371/journal.pone.0124373